Gsk Plc ADR(GSK-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low50.43
Day High51.94
Open:51.79
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
GSK’s ZEAL-1L Lung Cancer Trial Delivers Mixed Readout With Limited Upside for Niraparib
Tipranks
GSK Targets Relapsed B-Cell Lymphoma With New Early-Stage Trial
Zacks Investment Research
Biogen to Strengthen Immunology Pipeline With $1B RayThera Buyout
Biogen to Strengthen Immunology Pipeline With $1B RayThera Buyout
Tipranks
GlaxoSmithKline (GSK) Gets a Sell from Barclays
GlobeNewswire
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
Zacks Investment Research
The Zacks Analyst Blog Highlights Gilead Sciences, Merck and GSK
The Zacks Analyst Blog Highlights Gilead Sciences, Merck and GSK
Tipranks
UBS Keeps Their Hold Rating on GlaxoSmithKline (GSK)
Tipranks
GSK Opens New Front in Malaria Prevention With First-in-Human Antibody Trial
MarketBeat
MarketBeat Week in Review – 06/08 - 06/12
MarketBeat.com
Tipranks
TD Cowen Keeps Their Hold Rating on GlaxoSmithKline (GSK)
Tipranks
GSK Advances New COPD Candidate With Completed Phase 1 Ethnic-Sensitivity Study
Tipranks
GlaxoSmithKline (GSK) was upgraded to a Hold Rating at Intron Health
MarketBeat
Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion
MarketBeat.com
Tipranks
J.P. Morgan Keeps Their Sell Rating on GlaxoSmithKline (GSK)
Tipranks
Bernstein Gives a Buy Rating to GlaxoSmithKline (GSK)
Tipranks
UBS Remains a Hold on GlaxoSmithKline (GSK)
Tipranks
GlaxoSmithKline (GSK) Gets a Sell from Barclays
Tipranks
Deutsche Bank Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)
Tipranks
GSK’s New Pneumococcal Shot Reaches Key Milestone in Midlife Adult Trial

Profile

GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.